SCYNEXIS Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
JERSEY CITY, N.J., Dec. 03, 2023 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced grants of stock options to two new employees to purchase…